Works matching Myelofibrosis

Results: 4246
    1

    Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.

    Published in:
    Wiener Klinische Wochenschrift, 2017, v. 129, n. 9/10, p. 293, doi. 10.1007/s00508-016-1120-8
    By:
    • Sliwa, Thamer;
    • Beham-Schmid, Christine;
    • Burgstaller, Sonja;
    • Buxhofer-Ausch, Veronika;
    • Gastl, Günther;
    • Geissler, Klaus;
    • Krauth, Maria;
    • Krippl, Peter;
    • Lang, Alois;
    • Petzer, Andreas;
    • Wöhrer, Stefan;
    • Wölfler, Albert;
    • Gisslinger, Heinz
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 3, p. 326, doi. 10.1111/bjh.12384
    By:
    • DeAngelo, Daniel J.;
    • Mesa, Ruben A.;
    • Fiskus, Warren;
    • Tefferi, Ayalew;
    • Paley, Carole;
    • Wadleigh, Martha;
    • Ritchie, Ellen K.;
    • Snyder, David S.;
    • Begna, Kebede;
    • Ganguly, Siddhartha;
    • Ondovik, Michael S.;
    • Rine, Jessica;
    • Bhalla, Kapil N.
    Publication type:
    Article
    14
    15

    PEG-IFN-α-2a therapy in patients with myelofibrosis.

    Published in:
    2009
    By:
    • Ianotto, Jean-Christophe;
    • Kiladjian, Jean-Jacques;
    • Demory, Jean-Louis;
    • Roy, Lydia;
    • Boyer, Françoise;
    • Rey, Jerôme;
    • Dupriez, Brigitte;
    • Berthou, Christian;
    • Abgrall, Jean-François
    Publication type:
    Letter
    16
    17
    18

    Modern management of myelofibrosis.

    Published in:
    British Journal of Haematology, 2005, v. 128, n. 5, p. 583, doi. 10.1111/j.1365-2141.2004.05301.x
    By:
    • Cervantes, Francisco
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?

    Published in:
    European Journal of Haematology, 2017, v. 99, n. 1, p. 60, doi. 10.1111/ejh.12891
    By:
    • Lestang, Elsa;
    • Peterlin, Pierre;
    • Le Bris, Yannick;
    • Dubruille, Viviane;
    • Delaunay, Jacques;
    • Godon, Catherine;
    • Theisen, Olivier;
    • Blin, Nicolas;
    • Mahe, Beatrice;
    • Gastinne, Thomas;
    • Garnier, Alice;
    • Touzeau, Cyrille;
    • Voldoire, Maud;
    • Bene, Marie C.;
    • Le Gouill, Steven;
    • Milpied, Noel;
    • Mohty, Mohamad;
    • Moreau, Philippe;
    • Guillaume, Thierry;
    • Chevallier, Patrice
    Publication type:
    Article
    25
    26

    Ruxolitinib therapy for myelofibrosis in Austria.

    Published in:
    Wiener Klinische Wochenschrift, 2018, v. 130, n. 17/18, p. 495, doi. 10.1007/s00508-018-1365-5
    By:
    • Krauth, Maria-Theresa;
    • Burgstaller, Sonja;
    • Buxhofer-Ausch, Veronika;
    • Gastl, Günther;
    • Geissler, Klaus;
    • Keil, Felix;
    • Krippl, Peter;
    • Melchardt, Thomas;
    • Petzer, Andreas;
    • Rumpold, Holger;
    • Sliwa, Thamer;
    • Wöhrer, Stefan;
    • Wölfler, Albert;
    • Gisslinger, Heinz
    Publication type:
    Article
    27
    28
    29
    30

    Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 1, p. 97, doi. 10.1007/s00277-023-05528-4
    By:
    • Shide, Kotaro;
    • Takenaka, Katsuto;
    • Kitanaka, Akira;
    • Numata, Akihiko;
    • Kameda, Takuro;
    • Yamauchi, Takuji;
    • Inagaki, Atsushi;
    • Mizuno, Shohei;
    • Takami, Akiyoshi;
    • Ito, Shinichi;
    • Hagihara, Masao;
    • Usuki, Kensuke;
    • Maekawa, Takaaki;
    • Sunami, Kazutaka;
    • Ueda, Yasunori;
    • Tsutsui, Miyuki;
    • Ando, Miki;
    • Komatsu, Norio;
    • Ozawa, Keiya;
    • Kurokawa, Mineo
    Publication type:
    Article
    31

    Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 4, p. 529, doi. 10.1111/bjh.18440
    By:
    • Hernández‐Boluda, Juan‐Carlos;
    • Pastor‐Galán, Irene;
    • Arellano‐Rodrigo, Eduardo;
    • Raya, José‐María;
    • Pérez‐Encinas, Manuel;
    • Ayala, Rosa;
    • Ferrer‐Marín, Francisca;
    • Velez, Patricia;
    • Mora, Elvira;
    • Fox, María‐Laura;
    • Hernández‐Rivas, Jesús‐María;
    • Xicoy, Blanca;
    • Mata‐Vázquez, María‐Isabel;
    • García‐Fortes, María;
    • Pérez‐López, Raúl;
    • Angona, Anna;
    • Cuevas, Beatriz;
    • Senín, Alicia;
    • Ramírez, María‐José;
    • Ramírez‐Payer, Angel
    Publication type:
    Article
    32

    Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 6, p. 1065, doi. 10.1111/bjh.18329
    By:
    • Kosiorek, Heidi E.;
    • Scherber, Robyn M.;
    • Geyer, Holly L.;
    • Verstovsek, Srdan;
    • Langlais, Blake T.;
    • Mazza, Gina L.;
    • Gotlib, Jason;
    • Gupta, Vikas;
    • Padrnos, Leslie J.;
    • Palmer, Jeanne M.;
    • Fleischman, Angela;
    • Mesa, Ruben A.;
    • Dueck, Amylou C.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Practical management of myelofibrosis with ruxolitinib.

    Published in:
    Internal Medicine Journal, 2015, v. 45, n. 12, p. 1221, doi. 10.1111/imj.12921
    By:
    • Ho, P. J.;
    • Marlton, P.;
    • Tam, C.;
    • Stevenson, W.;
    • Ritchie, D.;
    • Bird, R.;
    • Dunlop, L. C.;
    • Durrant, S.;
    • Ross, D. M.
    Publication type:
    Article
    50